These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 25308586)

  • 1. Chronic inflammation of the prostate type IV with respect to risk of prostate cancer.
    Porcaro AB; Rubilotta E; Petrozziello A; Ghimenton C; Migliorini F; Zecchini Antoniolli S; Lacola V; Monaco C; Curti P; Cavalleri S; Pianon R; Artibani W
    Arch Ital Urol Androl; 2014 Sep; 86(3):208-11. PubMed ID: 25308586
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prostate volume index and chronic inflammation of the prostate type IV with respect to the risk of prostate cancer.
    Porcaro AB; Novella G; Molinari A; Terrin A; Minja A; De Marco V; Martignoni G; Brunelli M; Cerruto MA; Curti P; Cavalleri S; Artibani W
    Urol Int; 2015; 94(3):270-85. PubMed ID: 25170543
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prostate chronic inflammation type IV and prostate cancer risk in patients undergoing first biopsy set: Results of a large cohort study.
    Porcaro AB; Novella G; Balzarro M; Martignoni G; Brunelli M; Cacciamani G; Cerruto MA; Artibani W
    Asian J Urol; 2015 Oct; 2(4):224-232. PubMed ID: 29264150
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Does positive family history of prostate cancer increase the risk of prostate cancer on initial prostate biopsy?
    Elshafei A; Moussa AS; Hatem A; Ethan V; Panumatrassamee K; Hernandez AV; Jones JS
    Urology; 2013 Apr; 81(4):826-30. PubMed ID: 23434102
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intraprostatic chronic inflammation is associated with a reduced risk of prostate cancer in patients elected to a first random biopsy set.
    Porcaro AB; Novella G; de Luyk N; Corsi P; Cacciamani G; Sebben M; Tafuri A; Processali T; Cerasuolo M; Cerruto MA; Brunelli M; Siracusano S; Artibani W
    Tumori; 2017 Sep; 103(5):475-482. PubMed ID: 27834470
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chronic Inflammation in Prostate Biopsy Cores is an Independent Factor that Lowers the Risk of Prostate Cancer Detection and is Inversely Associated with the Number of Positive Cores in Patients Elected to a First Biopsy.
    Porcaro AB; Novella G; Mattevi D; Bizzotto L; Cacciamani G; Luyk ND; Tamanini I; Cerruto MA; Brunelli M; Artibani W
    Curr Urol; 2016 May; 9(2):82-92. PubMed ID: 27390581
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prostate cancer detection rate in patients with repeated extended 21-sample needle biopsy.
    Campos-Fernandes JL; Bastien L; Nicolaiew N; Robert G; Terry S; Vacherot F; Salomon L; Allory Y; Vordos D; Hoznek A; Yiou R; Patard JJ; Abbou CC; de la Taille A
    Eur Urol; 2009 Mar; 55(3):600-6. PubMed ID: 18597923
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Significance of atypical small acinar proliferation and extensive high-grade prostatic intraepithelial neoplasm in clinical practice.
    Adamczyk P; Wolski Z; Butkiewicz R; Nussbeutel J; Drewa T
    Cent European J Urol; 2014; 67(2):136-41. PubMed ID: 25140226
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inflammatory changes in biopsy specimens from patients with suspected prostate cancer.
    Adamczyk P; Wolski Z; Butkiewicz R; Nussbeutel J; Drewa T
    Cent European J Urol; 2013; 66(3):256-62. PubMed ID: 24707358
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The utility of PSA velocity in prediction of prostate cancer and high grade cancer after an initially negative prostate biopsy.
    Elshafei A; Li YH; Hatem A; Moussa AS; Ethan V; Krishnan N; Li J; Jones JS
    Prostate; 2013 Dec; 73(16):1796-802. PubMed ID: 24038200
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Associations of Transitional Zone Volume with Intraprostatic Chronic Inflammation and Prostate Cancer Risk in Patients Undergoing a First Random Biopsy Set.
    Porcaro AB; Mattevi D; Novella G; De Luyk N; Corsi P; Bizzotto L; De Marchi D; Sebben M; Tafuri A; Inverardi D; Processali T; Cerruto MA; Brunelli M; Siracusano S; Artibani W
    Curr Urol; 2018 Feb; 11(2):85-91. PubMed ID: 29593467
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prostate health index and prostate cancer gene 3 score but not percent-free Prostate Specific Antigen have a predictive role in differentiating histological prostatitis from PCa and other nonneoplastic lesions (BPH and HG-PIN) at repeat biopsy.
    De Luca S; Passera R; Fiori C; Bollito E; Cappia S; Mario Scarpa R; Sottile A; Franco Randone D; Porpiglia F
    Urol Oncol; 2015 Oct; 33(10):424.e17-23. PubMed ID: 26162485
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Atypical small acinar proliferation (ASAP): Is a repeat biopsy necessary ASAP? A multi-institutional review.
    Leone A; Gershman B; Rotker K; Butler C; Fantasia J; Miller A; Afiadata A; Amin A; Zhou A; Jiang Z; Sebo T; Mega A; Schiff S; Pareek G; Golijanin D; Yates J; Karnes RJ; Renzulli J
    Prostate Cancer Prostatic Dis; 2016 Mar; 19(1):68-71. PubMed ID: 26857145
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of the digital rectal examination as diagnostic test for prostate cancer detection in obese patients.
    Dell'Atti L
    J BUON; 2015; 20(6):1601-5. PubMed ID: 26854458
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pathological patterns of prostate biopsy in men with fluctuations of prostate cancer gene 3 score: a preliminary report.
    De Luca S; Passera R; Cappia S; Bollito E; Randone DF; Porpiglia F
    Anticancer Res; 2015 Apr; 35(4):2417-22. PubMed ID: 25862908
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of NIH-IV prostatitis on free and free-to-total PSA.
    Stancik I; Lüftenegger W; Klimpfinger M; Müller MM; Hoeltl W
    Eur Urol; 2004 Dec; 46(6):760-4. PubMed ID: 15548444
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Histological chronic prostatitis and high-grade prostate intra-epithelial neoplasia do not influence urinary prostate cancer gene 3 score.
    De Luca S; Passera R; Milillo A; Coda R; Randone DF
    BJU Int; 2012 Dec; 110(11 Pt B):E778-82. PubMed ID: 23116408
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The optimal rebiopsy prostatic scheme depends on patient clinical characteristics: results of a recursive partitioning analysis based on a 24-core systematic scheme.
    Scattoni V; Raber M; Capitanio U; Abdollah F; Roscigno M; Angiolilli D; Maccagnano C; Gallina A; Saccà A; Freschi M; Doglioni C; Rigatti P; Montorsi F
    Eur Urol; 2011 Oct; 60(4):834-41. PubMed ID: 21820797
    [TBL] [Abstract][Full Text] [Related]  

  • 19. PCA3-based nomogram for predicting prostate cancer and high grade cancer on initial transrectal guided biopsy.
    Elshafei A; Chevli KK; Moussa AS; Kara O; Chueh SC; Walter P; Hatem A; Gao T; Jones JS; Duff M
    Prostate; 2015 Dec; 75(16):1951-7. PubMed ID: 26384170
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Baseline prostate inflammation is associated with a reduced risk of prostate cancer in men undergoing repeat prostate biopsy: results from the REDUCE study.
    Moreira DM; Nickel JC; Gerber L; Muller RL; Andriole GL; Castro-Santamaria R; Freedland SJ
    Cancer; 2014 Jan; 120(2):190-6. PubMed ID: 24323568
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.